Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Holista Biotech Sdn Bhd has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution of this portfolio is currently localized in 1 distinct art unit, which handles the specific technical requirements of the company's filings. This indicates that the company's current intellectual property activity is focused on a specific niche within the broader biotechnology and pharmaceutical landscape.
The data identifies a distinct examiner involved in the current workload. CRAIGO, WILLIAM A is the busiest examiner for the portfolio, managing the pending office action. This single examiner is responsible for all current pending matters, centralizing the company's immediate patent prosecution efforts within a single point of contact at the patent office. For the applicant, this concentration means that the progression of the portfolio is currently dependent on the review of this specific examiner within the designated art unit, allowing for a very focused prosecution dialogue.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CRAIGO, WILLIAM A | 1 | 49.2% | +38.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18444429 | COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF | CRAIGO, WILLIAM A | 11d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18444429 | COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF | CRAIGO, WILLIAM A | 11d overdue |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18444429 | COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF | CRAIGO, WILLIAM A | 1615 | §103§112 | Non-Final OA | 11d overdue | Pending | Feb 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial